Abstract
The purpose of this study is to evaluate the prospect of using surface modified cobalt oxide(CoO) nanoparticles as carriers of cancerantigens to human macrophages. N-Phosnomethyliminodiacetic acid (PMIDA) was used for surface modification to overcome the toxic effect of CoO nanoparticles. Here, the phosphonate group of the PMIDA acts as a surface-anchoring agent and the remaining –COOH groups bind nonspecifically with tumor associated antigens. This modification allows the conjugation of human oral carcinoma (KB) cell lysate (CL) as an antigen with PMIDA coated CoO nanoparticles (CL–PMIDA–CoO). Particle characterization was performed by dynamic light scattering, atomic force microscopy, and scanning electron microscopy studies. Fourier transform IR spectroscopy was used to investigate conjugation of the protein with nanoparticles. Protein encapsulation was confirmed by protein gel electrophoresis. Active uptake of antigen-conjugated nanoparticles by macrophages was confirmed by fluorescence microscopy. The antitumor activity of the nanocomplex pulsed macrophages was investigated on a human oral carcinoma cell line (KB) in vitro. The modified nanocomplexes upregulate IFN-γ and TNF-α and induce an anticancer immune response by activating macrophages. The use of TNF-α inhibitor confirmed the ability of the CL–PMIDA–CoO nanocomplex to stimulate TNF-α mediated immunostimulation. CL–PMIDA–CoO nanoparticles efficiently increased the CD4+ population. Thus, our findings provide insight into the use of PMIDA coated CoO nanoparticles as antigen delivery vehicles.
Graphical abstract
Similar content being viewed by others
Abbreviations
- AFM:
-
Atomic force microscopy
- ASA:
-
Acetylsalicylic acid
- cAMP:
-
Cyclic adenosine monophosphate
- CL:
-
Cell lysate
- CL–PMIDA–CoO:
-
Cell lysate conjugated N-phosnomethyliminodiacetic acid coated cobalt oxide
- COX:
-
Cyclooxygenase
- DC:
-
Dendritic cell
- DLS:
-
Dynamic light scattering
- EDC:
-
N-Ethyl-N′-(3-dimethylaminopropyl)carbodiimide
- FCS:
-
Fetal calf serum
- IFN-γ:
-
Interferon-γ
- iNOS:
-
Inducible nitric oxide synthase
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NP:
-
Nanoparticle
- PBS:
-
Phosphate-buffered saline
- PMIDA:
-
N-Phosnomethyliminodiacetic acid
- PMIDA–CoO:
-
N-Phosnomethyliminodiacetic acid coated cobalt oxide
- POF:
-
Pentoxifylline
- RBC:
-
Red blood cell
- SDS-PAGE:
-
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
- SEM:
-
Scanning electron microscopy
- Th1:
-
Type 1 T helper
- Th2:
-
Type 2 T helper
References
Cheng J, Teply BA, Jeong SY, Yim CH, Ho D, Sherifi I, Jon S, Farokhzad OC, Khademhosseini A, Langer RS (2006) Pharm Res 23:557–564
Schreiber HA, Prechl J, Jiang H, Zozulya A, Fabry Z, Denes F, Sandor M (2010) J Immunol Methods 356:47–59
Tseng P, Carlo DD, Judy JW (2009) Nano Lett 9:3053–3059
Gupta RK, Chang AC, Siber GR (1998) Dev Biol Stand 92:63–78
Bandyopadhyay A, Fine RL, Demento S, Bockenstedt LK, Fahmy TM (2011) Biomaterials 32:3094–3105
Prasad S, Cody V, Saucier-Sawyer JK, Saltzman WM, Sasaki CT, Edelson RL, Birchall MA, Hanlon DJ (2011) Nanomed Nanotechnol Biol Med 7:1–10
Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, Korontsvit T, Zakhaleva V, Batt CA, Philips MR, Scheinberg DA (2011) ACS Nano 5:5300–5311
Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI (2008) ACS Nano 2:889–896
Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Small 1:325–327
Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Adv Drug Deliv Rev 60:1307–1315
Pissuwan D, Niidome T, Cortie MB (2009) J Control Release 149:65–71
Maus L, Dick O, Bading H, Spatz JP, Fiammengo R (2010) ACS Nano 4:6617–6628
Wang K, Xu JJ, Chen HY (2005) Biosens Bioelectron 20:1388–1396
Liu X, Qiu G, Li X (2005) Nanotechnology 16:3035–3040
Parkes LM, Hodgson R, Lu LT, Tung LD, Robinson I, Fernig DG, Thanh NT (2008) Contrast Media Mol Imaging 3:150–156
Papis E, Rossi F, Raspanti M, Isabella DD, Colombo G, Milzani A, Bernardini G, Gornati R (2009) Toxicol Lett 189:253–259
Dailey JP, Phillips JP, Li C, Riffle JS (1999) J Magn Magn Mater 194:140–148
Rutnakornpituk M, Baranauskas V, Riffle JS, Connolly J, Pierre TG, Dailey JP (2002) Eur Cells Mater 3:102–105
Pardoe H, Chua-anusorn W, Pierre TG, Dobson J (2001) J Magn Magn Mater 225:41–46
Hubert PM, Guerrero G, Vioux A (2005) J Mater Chem 15:3761–3768
Adden N, Gamble LJ, Castner DG, Hoffmann A, Gross G, Menzel H (2006) Langmuir 22:8197
Neouze MA, Schubert U (2008) Monatsh Chem 139:183–195
Chattopadhyay S, Chakraborty SP, Laha D, Baral R, Pramanik P, Roy S (2012) Cancer Nano 3:13–23
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) J Biol Chem 193:265–275
Sahu SK, Chakrabarty A, Bhattacharya D, Ghosh SK, Pramanik P (2011) J Nanopart Res 13:2475–2484
Ghosh T, Chattopadhyay T, Das S, Mondal S, Suresh E, Zangrando E, Das D (2011) Cryst Growth Des 11:3198–3205
Hudson L, Hay FC (1991) Practical immunology, 3rd edn. Blackwell, Melbourne, pp 21–22
Balasubramaniam P, Malathi A (1992) J Postgrad Med 38:8–9
Staudinger T, Presterl E, Graninger W, Locker GJ, Knapp S, Laczika K, Klappacher G, Stoiser B, Wagner A, Tesinsky P, Kordova H, Frass M (1996) Intensive Care Med 22:888–893
Hino M, Kohchi C, Nishizawa T, Yoshida A, Nakata K, Inagawa H, Hori H, Makino K, Terada H, Soma GI (2005) Anticancer Res 25:3747–3754
Yongbin M, Chen B, Zhang Y, Hou Y, Xie H, Xia G, Tang M, Huang X, Ni Y, Hu Q (2011) Int J Nanomed 6:1779–1786
Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U (1999) Am J Respir Crit Care Med 159:508–511
Okada M, Sagawa T, Tominaga A, Kodama T, Hitsumoto Y (1996) Immunology 89:158–164
Mohapatra S, Mallick SK, Maiti TK, Ghosh SK, Pramanik P (2007) Nanotechnology 18:385102–385111
Cho WS, Dart K, Nowakowska DJ, Zheng X, Donaldson K, Howie SE (2012) Nanomedicine 7:1495–1505
O’Hagan DT, Jeffery H, Davis SS (1994) Int J Pharm 103:37–45
Hans ML, Lowman AM (2002) Curr Opin Solid State Mater Sci 6:319–327
Audran R, Peter K, Dannull J, Men Y, Scandella E, Groettrup M (2003) Vaccine 21:1250–1255
Wood BR, Quinn MQ, Tait B, Romeo M, Mantsch HH (1998) Biospectroscopy 4:75–79
Banyay M, Sarkar M, Graslund A (2003) Biophys Chem 104:477–488
Anand KV, Chinnu MK, Kumar RM, Mohan R, Jayavel R (2010) J Alloys Compd 496:665–668
Hermanson GT (1996) Bioconjugate techniques. Academic, New York
Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI (2007) Environ Health Perspect 155:403–409
Tagawa M, Yumoto R, Oda K, Nagai J, Takano M (2008) Drug Metab Pharmacokinet 23:318
Wilson KT, Fu S, Ramanujam KS, Melzer SJ (1998) Cancer Res 58:2929–2934
Peters K, Unger RE, Gatti AM, Sabbioni E, Tsaryk R, Kirkpatrick C (2007) Int J Immunopathol Pharmacol 20:685–695
Lavnikova N, Drapier JC, Laskin DL (1993) J Leukoc Biol 54:322–328
Klimp AH, de Vries EG, Scherphof GL, Daemen T(2002) Crit Rev Oncol Hematol 44:143–161.
Morgan DL, Shines CJ (2004) Toxicol In Vitro 18:139–146
Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Proc Natl Acad Sci USA 90:7240–7244
Watkins DN, Garlepp MJ, Thompson PJ (1997) Br J Pharmacol 121:1482–1488
Kanematsu M, Keda K, Yamada Y (1997) J Bone Miner Res 12:1789–1796
Von Knethen A, Brune B (1997) FASEB J 11:887–895
Singer II, Kawka DW, Schloemann S, Terssner T, Riehl T, Stenson WF (1998) Gastroenterology 115:297–306
Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG (2009) Nanoscale Res Lett 4:1409–1420
Lappin MB, Campbell JD (2000) Blood Rev 14:228
Dong C, Flavell RA (2001) Curr Opin Hematol 8:47
Croft M (2009) Nat Rev Immunol 9:271
Katakami Y, Nakao Y, Oizumi TK, Katakami N, Ogawa R, Fujita T (1988) Immunology 64:719–724
Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D (1988) J Biol Chem 263:5380–5384
Spatafora M, Chiappara G, Merendino AM, Amico DD, Bellia V, Bonsignore G (1994) J Eur Respir 7:223–228
Endres S, Fulle HJ, Sincha B, Stoll D, Dinarello CA, Gerzer R, Weber PC (1991) Immunology 72:56–60
Huh PW, Kotasek D, Jacob HS, Vercellotti GM, Hammerschmidt DE (1985) Clin Res 33:866–878
Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch JP, Larrick J, Kunkel SL (1988) Biochem Biophys Res Commun 155:1230–1236
Schade UF (1990) Circ Shock 31:171–181
Schade UF (1989) Eicosanoids 2:183–187
Coccia MT, Waxman K, Soliman MH, Tominaga G, Pinderski L (1989) Crit Care Med 17:36
Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE (1995) Blood 86:1184–1195
Komada Y, Sakurai M (1997) Leuk Lymphoma 25:9–21
Williams MA, Newland AC, Kelsey SM (2000) Leuk Res 24:317–330
Acknowledgments
The authors express their gratefulness to the Department of Biotechnology, Government of India, for funding. The authors also express their gratefulness to the Indian Institute of Technology, Kharagpur and Vidyasagar University, Midnapore, for providing the facilities to execute these studies.
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chattopadhyay, S., Dash, S.K., Ghosh, T. et al. Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles. J Biol Inorg Chem 18, 957–973 (2013). https://doi.org/10.1007/s00775-013-1044-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-013-1044-y